X

The Health Sciences Blog covers the latest trends and advances in life sciences and healthcare.

Is Site-Centric Engagement Paramount to Clinical Trial Success?

Craig Morgan
Head of Marketing, Study Startup

Sponsors and contract research organizations (CROs) must continuously fight an uphill battle to reduce complexity, streamline business processes and workflows, ensure compliance and increase efficiencies at all scales. Fundamental to this goal is a site-centric approach to engagement with investigative sites.

Sites are dynamic environments, and new technology and industry initiatives are an important complement to the critical need for relationship building and maintenance. But are they helping improve site and sponsor-CRO collaboration, and creating a competitive edge through improved clinical trial performance?

A panel of site-centric industry organizations will present and discuss the findings from a new study aimed at addressing these questions. This webinar will outline the site perspective on these issues, which is of paramount importance in guiding and sustaining clinical research globally.

Please join us for this webcast:

Live: Tuesday, September 24, 2019

1pm EDT | 12pm CDT | 10am PDT

On Demand: available after airing until September 24, 2020

Register here.

This webcast will explore:

  • Explore changing site sentiment towards eClinical technology and how clinical trial conduct is impacted;
  • Understand the impact of site-centric industry initiatives, intentions and realities, and the impact of patient-centric studies on sites and future clinical operations;
  • Identify perceptions related to changing operational landscapes (e.g., Decentralized Clinical Trials).

This webcast is applicable to:

  • Investigative sites engaged or wishing to engage in clinical studies
  • Sponsor and CRO roles responsible for site identification, feasibility assessment, selection and activation
  • Sponsor and CRO roles responsible for project management of studies and operational excellence

Panelists:

 

CASEY ORVIN, President, Society for Clinical Research Sites (SCRS)

Casey Orvin is president of the Society for Clinical Research Sites (SCRS). With nearly 20 years of experience working with the site community, Orvin previously served as executive vice president of business development for Synexus, and vice president of marketing and sponsor recruitment for Clinical Research Advantage.

Orvin is a champion for clinical research sites with experience creating outreach programs, developing key partnerships, and generating study opportunities for hundreds of clinical research sites globally. He is an active community member and dedicated volunteer in the Phoenix area where he lives with his wife and three children.

 

BETH HARPER, Workforce Innovation Officer, Association of Clinical Research Professionals (ACRP)

Beth is the President of Clinical Performance Partners, Inc. a consulting firm specializing in enrollment and site performance optimization. Beth has passionately pursued solutions for optimizing clinical trials and educating clinical research professionals for over three decades.  Beth is also an Adjunct Assistant Professor at the George Washington University who has published and presented extensively in the areas of protocol optimization, study feasibility, site selection, patient recruitment and sponsor-site relationship management and clinical research professional competency.

Beth received her B. S. in Occupational Therapy from the University of Wisconsin and an M.B.A. from the University of Texas.

 

ANNICK ANDERSON, Director of Research Services, Center for Information & Study Research Participation (CISCRP)

Annick Anderson is the Director of Research Services at CISCRP.  She is responsible for the design, implementation, analysis and reporting of a variety of CISCRP research studies including the Perceptions & Insights studies and numerous Patient Advisory Boards.  She has more than 20 years of experience conducting primary and secondary research studies in the healthcare, life sciences and consumer goods industries.  She holds an MBA from the Graduate School of Management at Boston University and a Bachelor of Science degree from Bryant University.

 

KATHERINE VANDEBELT, Global Head of Clinical Innovation, Oracle Health Sciences

Katherine (Kathy) Vandebelt believes patients are the most important constituent in clinical development and provide the necessary information to assess the safety and efficacy of new medicines. Kathy is using the power of technology to introduce new experiences and expectations to make the clinical research ecosystem better for patients, healthcare providers, sponsors and regulators. With over thirty years of experience in clinical research working in different geographies and across various therapeutic areas, Kathy has worked with various organizations to advance their clinical operations and business processes to a better operating model.

Be the first to comment

Comments ( 0 )
Please enter your name.Please provide a valid email address.Please enter a comment.CAPTCHA challenge response provided was incorrect. Please try again.